Details: pack, label wording, sources, registration
Regenopia, Eye drops
eye drops 10 ml, medical device (human)
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
Adjunctive ocular-surface lubrication and tear-film support after examination, including dry-eye instability and temporary peri-anaesthetic or surface-protection roles
6.6/10
Situational / acceptable
Details →
vetman assessment
Regenopia
×
eye drops 10 ml, medical device (human)
Assessed clinical scope Dog · Adjunctive ocular-surface lubrication and tear-film support after examination, including dry-eye instability and temporary peri-anaesthetic or surface-protection roles · Into the eye
Care setting Veterinarian-directed clinic or home adjunct after excluding urgent painful-eye disease and defining the cause-specific plan.
vetman score
6.6/10
Situational / acceptable
Evidence confidence: Medium
Georgia: Not a medicine · Verified on 15 Oct 2026
Off-label use
A reasonable off-label preservative-free canine lubricant adjunct with direct class evidence, but not a tear stimulant or stand-alone KCS/ulcer treatment and without an exact-product veterinary schedule.
Regulatory and scientific credibility 6.0/10
Exact preservative-free composition, manufacturer, sterile technique, storage, after-opening limits and device directions are transparent, but the device is adult-human labelled, a conflicting 1.5% news-page typo exists and no exact-product veterinary dossier or outcome study is available.
Clinical efficacy 6.5/10
Artificial tears are an accepted adjunct in canine KCS and direct canine studies support hyaluronate or trehalose/HA tear-film effects, but formulations differ, cohorts are small/retrospective or uncontrolled and concurrent tear stimulants prevent attributing disease control to Regenopia.
Safety and tolerability 7.5/10
Preservative-free topical lubricants have low expected systemic exposure and generally favourable canine tolerance, but exact-combination repeated-use, ulcerated/damaged-cornea, postoperative and reproductive/juvenile safety are not established; contamination remains important.
Clinical practicality 6.5/10
One-drop multidose delivery and room-temperature storage are workable, but sterile technique, one-patient-only use, frequent administration when needed, multi-drop spacing and discard deadlines create real treatment-management burden; schedule must be individually titrated.
Full-course cost-effectiveness -
No verified current Georgian price and no uniform evidence-defined veterinary course; price not assessed.
Important safety and use flags
Off-label adult-human ocular medical device. It is an adjunctive lubricant, not antimicrobial, antiviral, anaesthetic, anti-inflammatory or tear-stimulating therapy. Painful, red, discharging, cloudy or vision-impaired eyes require examination. Exclude ulcer, foreign body, glaucoma, uveitis, infection and trauma before treating “dry eye.” No exact-product dog/cat outcome study or fixed veterinary schedule exists. Human one-drop 3–4-times-daily guidance is a comparator, not an automatic prescription. Official product material supports sodium hyaluronate 0.15%, trehalose 3% and D-panthenol 2%. Do not propagate the conflicting S-Lab news-page 1.5% hyaluronate typo. Do not touch the dropper tip to the eye, eyelid or another surface; never share a multidose bottle between patients and do not use a damaged container. Store dry at 5–35°C away from heat. After opening, use no longer than 30 continuous or 90 discontinuous days with breaks; discard remaining solution. For multiple ophthalmic products, the human instruction separates by at least 15 minutes and places Regenopia last. Confirm the patient-specific sequence so another medicine is not diluted. Stop for hypersensitivity or worsening blepharospasm, pain, redness, discharge, haze or vision. Lack of expected response requires re-examination, not simply more frequent drops. Lubrication may improve comfort but does not replace ciclosporin/tacrolimus or other cause-specific KCS therapy, ulcer treatment, antimicrobials, antivirals or surgery when indicated. Exact repeated-use safety on ulcerated/damaged cornea, after animal ocular surgery, in pregnancy/lactation or juveniles is not established; use only for a defined examined indication. Assessment sources +
Close
Cat
Adjunctive ocular-surface lubrication and tear-film support after examination, including dry-eye instability and temporary peri-anaesthetic or surface-protection roles
6.2/10
Situational / acceptable
Details →
vetman assessment
Regenopia
×
eye drops 10 ml, medical device (human)
Assessed clinical scope Cat · Adjunctive ocular-surface lubrication and tear-film support after examination, including dry-eye instability and temporary peri-anaesthetic or surface-protection roles · Into the eye
Care setting Veterinarian-directed clinic or home adjunct after excluding urgent painful-eye disease and defining the cause-specific plan.
vetman score
6.2/10
Situational / acceptable
Evidence confidence: Medium
Georgia: Not a medicine · Verified on 15 Oct 2026
Off-label use
A reasonable off-label feline lubricant adjunct with concentration-matched temporary tear-film evidence, but limited disease data and no exact-product feline regimen or outcome study.
Regulatory and scientific credibility 6.0/10
Exact preservative-free composition, manufacturer, sterile technique, storage, after-opening limits and device directions are transparent, but the device is adult-human labelled, a conflicting 1.5% news-page typo exists and no exact-product veterinary dossier or outcome study is available.
Clinical efficacy 5.5/10
A paired-eye study in 40 healthy anaesthetised cats directly supports temporary tear-film stability from one drop of 0.15% sodium hyaluronate, but it does not test chronic feline disease, trehalose/D-panthenol contributions or exact Regenopia outcomes.
Safety and tolerability 7.0/10
One-drop 0.15% hyaluronate exposure was tolerated in healthy anaesthetised cats and preservative-free topical exposure is reassuring, but exact-combination repeated-use, diseased-cornea, postoperative and reproductive/juvenile feline safety are unstudied.
Clinical practicality 6.5/10
One-drop multidose delivery and room-temperature storage are workable, but sterile technique, one-patient-only use, frequent administration when needed, multi-drop spacing and discard deadlines create real treatment-management burden; schedule must be individually titrated.
Full-course cost-effectiveness -
No verified current Georgian price and no uniform evidence-defined veterinary course; price not assessed.
Important safety and use flags
Off-label adult-human ocular medical device. It is an adjunctive lubricant, not antimicrobial, antiviral, anaesthetic, anti-inflammatory or tear-stimulating therapy. Painful, red, discharging, cloudy or vision-impaired eyes require examination. Exclude ulcer, foreign body, glaucoma, uveitis, infection and trauma before treating “dry eye.” No exact-product dog/cat outcome study or fixed veterinary schedule exists. Human one-drop 3–4-times-daily guidance is a comparator, not an automatic prescription. Official product material supports sodium hyaluronate 0.15%, trehalose 3% and D-panthenol 2%. Do not propagate the conflicting S-Lab news-page 1.5% hyaluronate typo. Do not touch the dropper tip to the eye, eyelid or another surface; never share a multidose bottle between patients and do not use a damaged container. Store dry at 5–35°C away from heat. After opening, use no longer than 30 continuous or 90 discontinuous days with breaks; discard remaining solution. For multiple ophthalmic products, the human instruction separates by at least 15 minutes and places Regenopia last. Confirm the patient-specific sequence so another medicine is not diluted. Stop for hypersensitivity or worsening blepharospasm, pain, redness, discharge, haze or vision. Lack of expected response requires re-examination, not simply more frequent drops. Lubrication may improve comfort but does not replace ciclosporin/tacrolimus or other cause-specific KCS therapy, ulcer treatment, antimicrobials, antivirals or surgery when indicated. Exact repeated-use safety on ulcerated/damaged cornea, after animal ocular surgery, in pregnancy/lactation or juveniles is not established; use only for a defined examined indication. Assessment sources +
Close
Administration route
Into the eye
Registration
Georgia
Not a medicine
Not applicable (not a medicine)
Product label (Medical device (label), not a medicine)
Verified on: 15 Oct 2026
EU
Not a medicine
Not applicable (not a medicine)
Verified on: 15 Oct 2026
UK
Not a medicine
Not applicable (not a medicine)
Verified on: 15 Oct 2026
US
Not a medicine
Not applicable (not a medicine)
Verified on: 15 Oct 2026
Controlled in Georgia
Unknown
Information not fully verified
No fixed dog/cat frequency is established for this exact device. The adult-human instruction is one drop as needed, usually 3–4 times daily and more often for severe symptoms; use only as a comparator and let ocular diagnosis, tear testing, retention and response determine the veterinary schedule. For multiple eye products, the human instruction separates by at least 15 minutes and places Regenopia last; confirm the animal-specific sequence. One patient per bottle. Store dry at 5–35°C; after opening use no longer than 30 continuous or 90 discontinuous days and discard unused solution.
